Cristin Flanagan

 1 2 3  

Moderna Funding Nears $1 Billion As Vaccine Study Starts

by

Government support for the vaccine “increases our confidence in its success,” an analyst said.

Goldman Predicts U.S. May Have A Covid-19 Vaccine By End Of Year

by

How quickly a vaccine could win regulatory approval has been the subject of much debate on Wall Street.

U.S. Airline Stocks Rally Ahead Of A Pickup In Summer Travel

by ,

The enthusiasm for airline stocks is spurring massive inflows in the exchange-traded fund market.

Gilead's Covid-19 Drug Seen In Short Supply For Americans

by

More than 300,000 eligible patients in the U.S. won’t have access to the California-based company’s treatment.

Goldman Names Health Stocks With Promising Covid-19 Efforts

by

The U.S. Food and Drug Administration is expediting development and review of new products to fight Covid-19.

Goldman Touts 'Safe' Bets When S&P 500 Dividends Set To Drop 25%

by

Some companies are expected to buck the trend of companies dropping their dividend.

Wall Street Renews Scrutiny Of Biden's Policies After New Wins

by ,

His specific policies are being more closely analyzed now that he's perceived to be the primary winner.

Health Insurance Stocks Rally On Biden Campaign Comeback

by

Wall Street looks on a candidacy of the former vice president more favorably than that of Senator Bernie Sanders.

Year’s Best U.S. IPO Is A Little-Known Biotech With 420% Surge

by

Karuna Therapeutics has had a remarkable run since its June IPO.

Baker Brothers Makes $730 Million In One Day On Its Biotech Bet

by

The investment firm founded by Felix and Julian Baker made a big bet in the company.

 1 2 3